What is Vivani Medical, Inc. (VANI) stock price today?

Vivani Medical, Inc. (VANI) is currently trading at $1.25, up 1.63% today.

What is VANI P/E ratio?

Vivani Medical, Inc.'s P/E ratio is -3.51. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is VANI return on equity (ROE)?

Vivani Medical, Inc.'s return on equity (ROE) is -191.05%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Vivani Medical, Inc.'s market cap?

Vivani Medical, Inc. has a market capitalization of $107.79M.

NASDAQ · Medical - Devices

Vivani Medical, Inc. (VANI) Stock

$1.25 +1.63% NASDAQ: VANI Healthcare

Valuation

Metric	Value
Price	$1.25
Market Cap	$107.79M
P/E Ratio	-3.51
P/B Ratio	5.65
P/S Ratio	0.00
EPS (TTM)	$-0.43
52-Week High	$1.92
52-Week Low	$0.92
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-191.05%
ROA	-63.19%
ROCE	-77.83%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.94
Current Ratio	2.57

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-13.0M	$-21.0M	$-27.0M	$-25.0M	$-28.0M
Net Profit	$-13.0M	$-14.0M	$-26.0M	$-23.0M	$-27.0M
EPS	$-0.33	$-0.17	$-0.50	$-0.43	$-0.43
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$5.0M	$51.0M	$46.0M	$42.0M	$39.0M
Total Liabilities	$3.0M	$7.0M	$25.0M	$24.0M	$24.0M
Cash	$2.0M	$45.0M	$21.0M	$18.0M	$16.0M
Borrowings	$2.0M	$1.0M	$21.0M	$19.0M	$19.0M

Latest News

Vivani Medical Insider Bought Shares Worth $999,999, According to a Recent SEC Filing MT Newswires · Jul 16, 2026 Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal MarketBeat · Jul 15, 2026 Vivani Medical to Present at the Emerging Growth Conference on July 15, 2026 GlobeNewswire · Jul 14, 2026 Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream GlobeNewswire · Jul 14, 2026 Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal Simply Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-9.0M	$-19.0M	$-24.0M	$-21.0M	$-24.0M
Investing Cash Flow	$0	$-1.0M	$-2.0M	$-1.0M	$-2.0M
Financing Cash Flow	$0	$55.0M	$0	$-19.0M	$0
Net Cash Flow	$66.0M	$44.0M	$-24.0M	$-2.0M	$-2.0M
Free Cash Flow	$-9.0M	$-19.0M	$-25.0M	$-21.0M	$-25.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.14
EV / EBITDA	-3.86
FCF Yield	-24.98%
Quick Ratio	3.25
Interest Coverage	0.00
Return 1Y	-8.55%
Return 3Y	12.10%
Return 5Y	-87.74%

Ownership

Insiders Held57.94%

Institutions Held6.48%

Institutions Float Held15.41%

Institutional Holder	Shares	Report Date
Vanguard Capital Management LLC	1,530,933	2026-03-31
Tanager Wealth Management LLP	641,085	2026-03-31
Geode Capital Management, LLC	600,578	2026-03-31
Tudor Investment Corp Et Al	426,302	2026-03-31
UBS Group AG	337,749	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CRDLCardiol Therapeutics Inc.	$1.23	-5.38%	-5.90	$141.78M	0.00%
EDAPEdap Tms S.a.	$4.76	-0.52%	-6.63	$178.23M	0.00%
FONR	$19.09	+0.00%	15.33	$117.76M	0.00%
HYPRHyperfine, Inc.	$0.93	-1.00%	-2.33	$78.38M	0.00%
IMAImageneBio, Inc.	$4.24	-0.47%	-0.87	$47.82M	0.00%

About Vivani Medical, Inc.

Vivani Medical, Inc. is led by CEO Adam Mendelsohn, employs 37 people, headquartered in US, publicly traded since 2014.

Vivani Medical, Inc. (VANI) stock trades at $1.25 with a market capitalization of $107.79M. The stock is valued at a price-to-earnings (P/E) ratio of -3.51, price-to-book of 5.65, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.92 and $1.92, and currently trades 34.9% below its 52-week high.

On profitability, Vivani Medical, Inc. generates a return on equity (ROE) of -191.05%, return on capital employed of -77.83%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides